These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 19638367

  • 1. Pulmonary effects of nebivolol.
    Dal Negro R.
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):329-34. PubMed ID: 19638367
    [Abstract] [Full Text] [Related]

  • 2. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW.
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [Abstract] [Full Text] [Related]

  • 3. Nitric oxide mechanisms of nebivolol.
    Maffei A, Lembo G.
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
    [Abstract] [Full Text] [Related]

  • 4. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA.
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [Abstract] [Full Text] [Related]

  • 5. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
    Rozec B, Erfanian M, Laurent K, Trochu JN, Gauthier C.
    J Am Coll Cardiol; 2009 Apr 28; 53(17):1532-8. PubMed ID: 19389564
    [Abstract] [Full Text] [Related]

  • 6. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J, Faülhaber HD.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():77-82. PubMed ID: 15700490
    [Abstract] [Full Text] [Related]

  • 7. [Efficacy of nebivolol in patients with coronary heart disease and concomitant chronic obstructive pulmonary disease].
    Kotliarov AA, Mosina LM, Chibisov SM, Selezneva NM, Shmyreva MV, Efremova EN, Surotkina SA.
    Klin Med (Mosk); 2011 Jul 27; 89(1):44-8. PubMed ID: 21516766
    [Abstract] [Full Text] [Related]

  • 8. [Administration of cardioselective beta-adrenoblockers in patients with arterial hypertension and/or ischemic heart disease associated with bronchoobstructive syndrome].
    Ovcharenko SI, Litvinova IV, Mikolkin VI.
    Ter Arkh; 2007 Jul 27; 79(9):12-8. PubMed ID: 18038580
    [Abstract] [Full Text] [Related]

  • 9. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
    Gupta S, Wright HM.
    Cardiovasc Ther; 2008 Jul 27; 26(3):189-202. PubMed ID: 18786089
    [Abstract] [Full Text] [Related]

  • 10. Nebivolol: in the treatment of hypertension in the US.
    Baldwin CM, Keam SJ.
    Am J Cardiovasc Drugs; 2009 Jul 27; 9(4):253-60. PubMed ID: 19655820
    [Abstract] [Full Text] [Related]

  • 11. Comparative effects of a two-week treatment with nebivolol and nifedipine in hypertensive patients suffering from COPD.
    Cazzola M, Matera MG, Ruggeri P, Sanduzzi A, Spicuzza L, Vatrella A, Girbino G.
    Respiration; 2004 Jul 27; 71(2):159-64. PubMed ID: 15031571
    [Abstract] [Full Text] [Related]

  • 12. [Nebivolol, a beta blocker of the 3rd generation: modern therapy of arterial hypertension. Results of a multicenter observation study].
    von Fallois J, Faulhaber HD.
    Praxis (Bern 1994); 2001 Mar 15; 90(11):435-41. PubMed ID: 11293936
    [Abstract] [Full Text] [Related]

  • 13. Nebivolol: the somewhat-different beta-adrenergic receptor blocker.
    Münzel T, Gori T.
    J Am Coll Cardiol; 2009 Oct 13; 54(16):1491-9. PubMed ID: 19815121
    [Abstract] [Full Text] [Related]

  • 14. Evolving mechanisms of action of beta blockers: focus on nebivolol.
    Mason RP, Giles TD, Sowers JR.
    J Cardiovasc Pharmacol; 2009 Aug 13; 54(2):123-8. PubMed ID: 19528811
    [Abstract] [Full Text] [Related]

  • 15. Beta-blockers in the management of hypertension: focus on nebivolol.
    Wojciechowski D, Papademetriou V.
    Expert Rev Cardiovasc Ther; 2008 Apr 13; 6(4):471-9. PubMed ID: 18402537
    [Abstract] [Full Text] [Related]

  • 16. Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.
    Prisant LM.
    J Clin Pharmacol; 2008 Feb 13; 48(2):225-39. PubMed ID: 18083889
    [Abstract] [Full Text] [Related]

  • 17. Nebivolol: new therapy update.
    Sule SS, Frishman W.
    Cardiol Rev; 2006 Feb 13; 14(5):259-64. PubMed ID: 16924166
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of pulmonary hypertension in COPD: is there hope for the better?].
    Tesloianu A, Eşanu V, Mihăescu T, Spiridon M, Tesloianu D.
    Pneumologia; 2004 Feb 13; 53(4):147-54. PubMed ID: 16106721
    [Abstract] [Full Text] [Related]

  • 19. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
    Pronko TP, Zinchuk VV.
    Clin Physiol Funct Imaging; 2009 May 13; 29(3):170-6. PubMed ID: 19170724
    [Abstract] [Full Text] [Related]

  • 20. Nebivolol: third-generation beta-blockade.
    de Boer RA, Voors AA, van Veldhuisen DJ.
    Expert Opin Pharmacother; 2007 Jul 13; 8(10):1539-50. PubMed ID: 17661735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.